{"id":119257,"date":"2026-10-26T12:45:42","date_gmt":"2026-10-26T09:45:42","guid":{"rendered":"https:\/\/prizrenpost.com\/al\/nje-epoke-e-re-ne-onkologji\/"},"modified":"2026-10-26T12:45:42","modified_gmt":"2026-10-26T09:45:42","slug":"nje-epoke-e-re-ne-onkologji","status":"publish","type":"post","link":"https:\/\/prizrenpost.com\/al\/nje-epoke-e-re-ne-onkologji\/","title":{"rendered":"Nj\u00eb epok\u00eb e re n\u00eb onkologji"},"content":{"rendered":"<figure class=\"post-featured-image\"><img decoding=\"async\" src=\"https:\/\/prizrenpost.com\/al\/wp-content\/uploads\/2026\/10\/kontrola-melanoma-inz-zdk-maj-2023-3.webp\" alt=\"Nj\u00eb epok\u00eb e re n\u00eb onkologji\"\/><\/figure>\n<p>Kan\u00eb kaluar 20 vjet q\u00eb kur studiuesit australian\u00eb krijuan vaksin\u00ebn e par\u00eb n\u00eb bot\u00eb t\u00eb zhvilluar posa\u00e7\u00ebrisht p\u00ebr parandalimin e kancerit. Fal\u00eb vaksin\u00ebs HPV, Australia \u00ebsht\u00eb n\u00eb rrug\u00ebn e duhur p\u00ebr t\u2019u b\u00ebr\u00eb nj\u00eb nga vendet e para n\u00eb bot\u00eb q\u00eb eliminon kancerin e qaf\u00ebs s\u00eb mitr\u00ebs. Tani, hulumtimi i udh\u00ebhequr nga shkenc\u00ebtar\u00eb nga ky kontinent ka b\u00ebr\u00eb nj\u00eb tjet\u00ebr p\u00ebrparim \u2013 k\u00ebt\u00eb her\u00eb p\u00ebr kancerin e l\u00ebkur\u00ebs.<\/p>\n<p>Vaksina e par\u00eb e personalizuar e mRNA-s\u00eb kund\u00ebr kancerit tani ka kaluar me sukses faz\u00ebn e tret\u00eb t\u00eb provave klinike, duke ulur rrezikun e p\u00ebrs\u00ebritjes s\u00eb melanom\u00ebs ose vdekjes me 42 p\u00ebrqind krahasuar vet\u00ebm me imunoterapin\u00eb standarde.<\/p>\n<p>Rezultatet jan\u00eb edhe m\u00eb t\u00eb mira nga sa kishin pritur shkenc\u00ebtar\u00ebt. Studiuesja kryesore globale, onkologia mjek\u00ebsore Georgina Long e Institutit t\u00eb Melanom\u00ebs s\u00eb Australis\u00eb (MIA), prezantoi rezultatet n\u00eb Kongresin e Shoq\u00ebris\u00eb Evropiane p\u00ebr Onkologji Mjek\u00ebsore 2026, dhe ato pritet t\u00eb publikohen n\u00eb New England Journal of Medicine.<\/p>\n<p>\u201cK\u00ebto gjetje p\u00ebrfaq\u00ebsojn\u00eb nj\u00eb ndryshim themelor n\u00eb qasjen ton\u00eb ndaj kancerit: shfryt\u00ebzimin e sistemit imunitar n\u00eb nj\u00eb m\u00ebnyr\u00eb m\u00eb t\u00eb personalizuar p\u00ebr t\u00eb zvog\u00ebluar rrezikun e rikthimit ose vdekjes s\u00eb melanom\u00ebs\u201d, thot\u00eb Long.<\/p>\n<p>\u201cKjo nuk \u00ebsht\u00eb b\u00ebr\u00eb kurr\u00eb m\u00eb par\u00eb n\u00eb historin\u00eb e zhvillimit t\u00eb ila\u00e7eve kund\u00ebr kancerit.\u201d<\/p>\n<p>Onkologu mjek\u00ebsor Robert Vonderheide, president i zgjedhur i Shoqat\u00ebs Amerikane p\u00ebr K\u00ebrkimin e Kancerit, i cili nuk ishte i p\u00ebrfshir\u00eb n\u00eb prov\u00eb, i tha The New York Times se rezultatet e prov\u00ebs renditen midis \u201carritjeve tona m\u00eb t\u00eb m\u00ebdha shkencore\u201d.<\/p>\n<p>Vaksina mRNA u zhvillua nga Moderna dhe Merck dhe \u00ebsht\u00eb projektuar p\u00ebr t\u00eb parandaluar rikthimin e melanom\u00ebs pas operacionit.<\/p>\n<p>S\u00eb pari, studiuesit renditin tumorin e secilit pacient, pastaj p\u00ebrcaktojn\u00eb se \u00e7far\u00eb i dallon qelizat tumorale nga qelizat e tjera t\u00eb sh\u00ebndetshme n\u00eb trup. Bazuar n\u00eb k\u00ebt\u00eb informacion, vaksina n\u00eb thelb krijon nj\u00eb \u2018list\u00eb d\u00ebshirash\u2019 t\u00eb personalizuar p\u00ebr kancerin p\u00ebr sistemin imunitar t\u00eb pacientit.<\/p>\n<p>\u201cKjo administrohet si ARNm, k\u00ebshtu q\u00eb qelizat e vet\u00eb trupit i paraqesin sistemit imunitar nj\u00eb \u2018list\u00eb d\u00ebshirash\u2019, duke i treguar atij sakt\u00ebsisht se \u00e7far\u00eb duhet t\u00eb k\u00ebrkoj\u00eb dhe \u00e7far\u00eb t\u00eb sulmoj\u00eb\u201d, shpjegon Long.<\/p>\n<p>Ila\u00e7i funksionon n\u00eb kombinim me nj\u00eb imunoterapi ekzistuese t\u00eb quajtur Keytruda (pembrolizumab).<\/p>\n<p>\u201cKanceri mund ta mashtroj\u00eb sistemin imunitar duke e b\u00ebr\u00eb t\u00eb mendoj\u00eb se nj\u00eb qeliz\u00eb kancerogjene \u00ebsht\u00eb normale duke b\u00ebr\u00eb nj\u00eb shtr\u00ebngim duarsh miq\u00ebsor, i cili i lejon sistemit imunitar t\u00eb njoh\u00eb dhe sulmoj\u00eb kancerin, por \u00ebsht\u00eb i nj\u00ebjti ila\u00e7 p\u00ebr t\u00eb gjith\u00eb pacient\u00ebt\u201d, shpjegon Long.<\/p>\n<p>Personalizimi i trajtimit t\u00eb p\u00ebrdorur me pembrolizumab duket se p\u00ebrmir\u00ebson rezultatet.<\/p>\n<p>Studim klinik i faz\u00ebs 3 regjistroi m\u00eb shum\u00eb se 1,100 pacient\u00eb nga 157 vende n\u00eb t\u00eb gjith\u00eb bot\u00ebn, dhe rezultatet konfirmojn\u00eb gjetjet mbres\u00ebl\u00ebn\u00ebse nga studimi i faz\u00ebs 2, i botuar n\u00eb vitin 2024.<\/p>\n<p>P\u00ebr pacient\u00ebt, kanceri i t\u00eb cil\u00ebve nuk ishte rikthyer gjasht\u00eb muaj pas fillimit t\u00eb trajtimit, rreziku i rikthimit ose vdekjes s\u00eb melanom\u00ebs u ul me 58 p\u00ebrqind.<\/p>\n<p>Vaksina mRNA nuk \u00ebsht\u00eb ende e disponueshme p\u00ebr pacient\u00ebt n\u00eb Australi ose Shtetet e Bashkuara, por rezultatet kan\u00eb hyr\u00eb n\u00eb procesin e shqyrtimit rregullator. \/tesheshi.com\/<\/p>\n<hr style=\"margin:30px 0\"\/>\n<p style=\"font-size:13px;color:#666\">Burimi: <strong>tesheshi<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kan\u00eb kaluar 20 vjet q\u00eb kur studiuesit australian\u00eb krijuan vaksin\u00ebn e par\u00eb n\u00eb bot\u00eb t\u00eb zhvilluar posa\u00e7\u00ebrisht p\u00ebr parandalimin e kancerit. Fal\u00eb vaksin\u00ebs HPV, Australia \u00ebsht\u00eb n\u00eb rrug\u00ebn e duhur p\u00ebr t\u2019u b\u00ebr\u00eb nj\u00eb nga vendet e para n\u00eb bot\u00eb q\u00eb eliminon kancerin e qaf\u00ebs s\u00eb mitr\u00ebs. Tani, hulumtimi i udh\u00ebhequr nga shkenc\u00ebtar\u00eb nga ky [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":119256,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-119257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-teknologji"],"_links":{"self":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/119257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/comments?post=119257"}],"version-history":[{"count":0,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/119257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media\/119256"}],"wp:attachment":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media?parent=119257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/categories?post=119257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/tags?post=119257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}